Propolis Wax
drug drugOn this page
Also known as Bee propolisFengjiaoPropolisPropolis cera
Summary
Propolis Wax (CHEMBL4298075) is a phase-3 clinical-stage small molecule; indicated across 10 conditions including chronic kidney disease and dental pulp disorder.
At a glance
- Status: Max clinical phase 3 (not approved)
- Modality: Small molecule
- Indications: 10 conditions
- Clinical trials: 45
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL4298075 |
| Name | Propolis Wax |
| Type | Small molecule |
| Max phase | 3 |
Also known as: Bee propolis, Fengjiao, Propolis, Propolis cera, Propolis wax, PROPOLIS WAX
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
7 diseases in clinical trials (phase 1–3, investigational — not approved indications). Highest ChEMBL trial phase per disease; a non-cancer approved use is occasionally logged at phase 3 here.
| Disease (in trials) | Phase | MONDO | EFO |
|---|---|---|---|
| chronic kidney disease | 2 | MONDO:0005300 | EFO:0003884 |
| dental pulp disorder | 2 | MONDO:0003394 | EFO:0009540 |
| severe acute respiratory syndrome | 2 | MONDO:0005091 | MONDO:0100096 |
| type 2 diabetes mellitus | 2 | MONDO:0005148 | MONDO:0005148 |
| allergic disease | 2 | MONDO:0005271 | MONDO:0005271 |
| dental caries | 2 | MONDO:0005276 | EFO:0003819 |
| periodontal disorder | 2 | MONDO:0002635 | MONDO:0002635 |
2 further indication records had no mapped disease name (EFO/MeSH-only) or were duplicates, and are omitted.
Clinical trials
Total trials: 45.
Phase distribution
| Phase | Trials |
|---|---|
| Not specified | 25 |
| PHASE2 | 7 |
| PHASE3 | 4 |
| PHASE4 | 3 |
| EARLY_PHASE1 | 3 |
| PHASE2/PHASE3 | 2 |
| PHASE1/PHASE2 | 1 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT06903546 | PHASE4 | RECRUITING | The Effect of Propolis Administration on Cholesterol Level in Diabetic Type 2 Patients |
| NCT02794506 | PHASE4 | COMPLETED | Propolis Improves Glycemic Control in Subjects With Type 2 Diabetes and Chronic Periodontitis |
| NCT03533231 | PHASE4 | COMPLETED | Efficiency of Triple Antibiotic Paste, Ciprofloxacin/Propolis, Ciprofloxacin/Metronidazole, Propolis/Metronidazole Combinations on Revascularization Process of Immature Necrotic Maxillary Incisors of Patients 8-18 Years Old. |
| NCT01750801 | PHASE3 | UNKNOWN | Efficacy of a Mouthwash Containing Propolis |
| NCT02818803 | PHASE3 | COMPLETED | Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic |
| NCT03723980 | PHASE3 | COMPLETED | Role of Propolis Paste in Preventing Pain After Root Canal Treatment. |
| NCT04819867 | PHASE2/PHASE3 | COMPLETED | Comparison Of The Effect Of Propolis And Gluma Desensitizer On The Management Of Dentin Hypersensitivity |
| NCT05974748 | PHASE3 | COMPLETED | Role of Propolis Endodontic Irrigant on Post-Operative Pain |
| NCT06455007 | PHASE2/PHASE3 | COMPLETED | Propolis as a Treatment Option for Hand Foot and Mouth Disease |
| NCT07073092 | PHASE2 | NOT_YET_RECRUITING | Propolis for Management of Chemotherapy-Induced Oral Mucositis in Pediatric Patients |
| NCT01375088 | PHASE2 | COMPLETED | Assessing the Preventing and Therapeutic Effect of Propolis in Radiotherapy Induced Mucositis of Head and Neck Cancers |
| NCT02052973 | PHASE1/PHASE2 | COMPLETED | Efficacy of Propolis Varnish Against Oral Biofilm |
| NCT02766036 | PHASE2 | COMPLETED | Propolis Effects in Patients With Chronic Kidney Disease |
| NCT03416127 | PHASE2 | COMPLETED | Effect of Propolis or Metformin Administration on Glycemic Control in Patients With Type 2 Diabetes Mellitus |
| NCT03580135 | PHASE2 | UNKNOWN | Postoperative Pain Evaluation of Mineral Trioxide Aggregate and Propolis After Pulpotomy in Carious Primary Molars |
| NCT03812315 | PHASE2 | COMPLETED | Antimicrobial Effect OF Propolis Administrated Through Two Different Vehicles In High Caries Risk Children |
| NCT05870059 | PHASE2 | COMPLETED | Comparative Evaluation of Propolis Mouthwash With 0.2% Chlorhexidine Mouthwash in Improving the Periodontitis |
| NCT04374006 | EARLY_PHASE1 | COMPLETED | Effects of Sulawesi Propolis Extract on Lesion Growth, Apoptotic and Inflammatory Activity of the Rat Endometriosis Tissue |
| NCT04754763 | EARLY_PHASE1 | COMPLETED | A Comparative Study On The Effect Of Propolis And Dentine Bonding Agent In Treating Dentine Hypersensitivity |
| NCT05413096 | EARLY_PHASE1 | COMPLETED | Combination of Diclofenac Potassium and Propolis in the Therapy of Oral Aphthosis |
| NCT05183737 | Not specified | ACTIVE_NOT_RECRUITING | Effects of Microencapsulated Propolis and Turmeric in Patients With Chronic Kidney Disease |
| NCT07578311 | Not specified | NOT_YET_RECRUITING | Effect of a Herbal Intracanal Medication On Postoperative Pain And Flare up Incidence In Non Surgical Root Canal Retreatment |
| NCT07596992 | Not specified | NOT_YET_RECRUITING | Effects of Royal Jelly and Propolis on Metabolomic Signatures, Inflammation, and Cardiovascular Risk in Patients With Coronary Artery Disease. |
| NCT01943877 | Not specified | UNKNOWN | Propolis In The Treatment Of Periodontitis |
| NCT03591172 | Not specified | UNKNOWN | Using Three Different Final Irrigants and Showing Their Effects on the Success of Revascularization |
| NCT03623048 | Not specified | UNKNOWN | Effect of Natural Antibacterial Mouthwash on Taste, Salivary pH and Bacteria in High Caries Risk pt |
| NCT03649243 | Not specified | COMPLETED | Propolis as Adjuvant in the Healing of Human Diabetic Foot Wounds |
| NCT04032548 | Not specified | COMPLETED | Effectiveness of Propolis Mouthwash on Gingivitis |
| NCT04117451 | Not specified | COMPLETED | The Effect of Propolis Mouthwash Compared to Chlorhexidine Mouthwash on Oral and Cardiovascular Health |
| NCT04145102 | Not specified | COMPLETED | Evaluation of the Remineralizing and Antibacterial Effect of Natural Versus Synthetic Materials on Deep Carious Dentin |
| NCT04382079 | Not specified | COMPLETED | Honey Products for Cancer Patients With Oral Mucositis: a Randomized Controlled Trial |
| NCT04411758 | Not specified | COMPLETED | Propolis for Patients With Chronic Kidney Disease. |
| NCT04680819 | Not specified | UNKNOWN | Evaluation of the Effect of Anatolian Propolis on Covid-19 in Healthcare Professionals |
| NCT04843644 | Not specified | UNKNOWN | Microbiota and Symptom Distress in Head and Neck Cancer Patients Receiving Radiotherapy |
| NCT04916821 | Not specified | UNKNOWN | Investigation of Clinical Effectiveness of Propolis Extracts as Food Supplements in Patients With SARS-CoV-2(COVID-19) |
| NCT04983524 | Not specified | COMPLETED | Propolis Versus Calcium Hydroxide on Post-Operative Pain in Patients With Necrotic Pulp |
| NCT05083052 | Not specified | COMPLETED | Propolis in Reducing Dentin Hypersensitivity |
| NCT05400031 | Not specified | COMPLETED | Oral Care With Propolis in Pediatric Oncology Patients |
| NCT05569590 | Not specified | COMPLETED | Efficacy of Desensitizing Agent,Propolis After an In-office Vital Tooth Bleaching. |
| NCT05625841 | Not specified | UNKNOWN | Effects for Oral Mucositis Care During Chemoradiotherapy in Cancer Patients: Evaluation of the Bee Products |
| NCT05717881 | Not specified | COMPLETED | Impact of Poplar Propolis on Metabolic Disturbances of Insulin Resistance |
| NCT05770297 | Not specified | UNKNOWN | Effect of Propolis Administration for Dysmenorrhea in Endometriosis Patient With Levonorgestrel Implant Therapy |
| NCT06216262 | Not specified | COMPLETED | Evaluation of the Effectiveness of Home-Use Desensitizing Agents on Dentin Hypersensitivity |
| NCT06936228 | Not specified | COMPLETED | Evaluation of the Effect of Local Propolis Application on the Healing of Pressure Ulcers |
| NCT07197073 | Not specified | COMPLETED | Antibacterial Effect of Ozonated Olive Oil, Propolis and Chlorhexidine Mouthwashes in Pediatric Patients |
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).